{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:55:06Z","timestamp":1760028906024,"version":"3.37.3"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Astra Zeneca AG"},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Terumo and Philips Volcano"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1093\/ehjcvp\/pvy031","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T11:11:48Z","timestamp":1533640308000},"page":"158-163","source":"Crossref","is-referenced-by-count":10,"title":["Influence of intravenous fentanyl compared with morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the PERSEUS randomized trial"],"prefix":"10.1093","volume":"5","author":[{"given":"Sophie","family":"Degrauwe","sequence":"first","affiliation":[{"name":"Department of Cardiology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Lauriers","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Lausanne University Hospital, Rue du Bugnon 46, Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Muller","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Lausanne University Hospital, Rue du Bugnon 46, Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Giorgio","family":"Masci","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Lausanne University Hospital, Rue du Bugnon 46, Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bern University Hospital, Freiburgstrasse 4, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan F","family":"Iglesias","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"key":"2019061805000249000_pvy031-B1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2019061805000249000_pvy031-B2","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/eurheartj\/ehp159","article-title":"Pharmacodynamic assessment of platelet inhibition by prasugrel vs. Clopidogrel in the TRITON-TIMI 38 trial","volume":"30","author":"Michelson","year":"2009","journal-title":"Eur Heart J"},{"key":"2019061805000249000_pvy031-B3","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jacc.2010.03.100","article-title":"Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy","volume":"56","author":"Storey","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2019061805000249000_pvy031-B4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial","volume":"373","author":"Montalescot","year":"2009","journal-title":"Lancet"},{"key":"2019061805000249000_pvy031-B5","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","article-title":"Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis","volume":"122","author":"Steg","year":"2010","journal-title":"Circulation"},{"key":"2019061805000249000_pvy031-B6","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jacc.2010.07.012","article-title":"New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis","volume":"56","author":"Bellemain-Appaix","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2019061805000249000_pvy031-B7","first-page":"e362","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"2019061805000249000_pvy031-B8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N Engl J Med"},{"key":"2019061805000249000_pvy031-B9","doi-asserted-by":"crossref","first-page":"e005528.","DOI":"10.1161\/CIRCINTERVENTIONS.117.005528","article-title":"No benefit of ticagrelor pretreatment compared with treatment during percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"11","author":"Koul","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"2019061805000249000_pvy031-B10","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jacc.2013.01.024","article-title":"Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: rAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study","volume":"61","author":"Parodi","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2019061805000249000_pvy031-B11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jacc.2013.10.068","article-title":"Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Hobl","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2019061805000249000_pvy031-B12","doi-asserted-by":"crossref","first-page":"e001593.","DOI":"10.1161\/CIRCINTERVENTIONS.114.001593","article-title":"Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"8","author":"Parodi","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"2019061805000249000_pvy031-B13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/eurheartj\/ehv547","article-title":"Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial","volume":"37","author":"Kubica","year":"2016","journal-title":"Eur Heart J"},{"key":"2019061805000249000_pvy031-B14","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1311096","article-title":"Bivalirudin started during emergency transport for primary PCI","volume":"369","author":"Steg","year":"2013","journal-title":"N Engl J Med"},{"key":"2019061805000249000_pvy031-B15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2125.1975.tb00568.x","article-title":"Inhibition of gastric emptying and drug absorption by narcotic analgesics","volume":"2","author":"Nimmo","year":"1975","journal-title":"Br J Clin Pharmacol"},{"key":"2019061805000249000_pvy031-B16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.cjca.2014.03.034","article-title":"Sedation, analgesia, and anaesthesia variability in laboratory-based cardiac procedures: an international survey","volume":"30","author":"Lavi","year":"2014","journal-title":"Can J Cardiol"},{"key":"2019061805000249000_pvy031-B17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.117.031678","article-title":"Effect of intravenous fentanyl on ticagrelor absorption and platelet inhibition among patients undergoing percutaneous coronary intervention: the PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl)","volume":"137","author":"McEvoy","year":"2018","journal-title":"Circulation"},{"key":"2019061805000249000_pvy031-B18","doi-asserted-by":"crossref","first-page":"e001593","DOI":"10.1161\/CIRCINTERVENTIONS.114.001593","article-title":"Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"8","author":"Parodi","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"2019061805000249000_pvy031-B19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1160\/TH15-12-0944","article-title":"P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC study","volume":"116","author":"Silvain","year":"2016","journal-title":"Thromb Haemost"},{"key":"2019061805000249000_pvy031-B20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ahj.2016.04.004","article-title":"The on- and off-target effects of morphine in acute coronary syndrome: a narrative review","volume":"176","author":"McCarthy","year":"2016","journal-title":"Am Heart J"},{"key":"2019061805000249000_pvy031-B21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1254\/jphs.09139FP","article-title":"Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models","volume":"111","author":"Minami","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"2019061805000249000_pvy031-B22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15360288.2011.620689","article-title":"Distinct relations among plasma concentrations required for different pharmacological effects in oxycodone, morphine, and fentanyl","volume":"25","author":"Nakamura","year":"2011","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"2019061805000249000_pvy031-B23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1124\/jpet.113.204313","article-title":"Mechanisms that underlie \u03bc-opioid receptor agonist-induced constipation: differential involvement of \u03bc-opioid receptor sites and responsible regions","volume":"347","author":"Mori","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"2019061805000249000_pvy031-B24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40265-017-0727-z","article-title":"Fentanyl formulations in the management of pain: an update","volume":"77","author":"Schug","year":"2017","journal-title":"Drugs"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/5\/3\/158\/28825518\/pvy031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T21:38:19Z","timestamp":1661722699000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/5\/3\/158\/5068133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,8,8]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvy031","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"type":"print","value":"2055-6837"},{"type":"electronic","value":"2055-6845"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2018,8,8]]}}}